| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_643f010666c91b6a4f877d79cebdea8a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2010-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4c6b58c2d4f627d95f29cdfb9d160c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e1030683093bca543c656050995afa1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce99b8a129141e83b1812a6e5db848b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55225d4d772e8fcef1fa3311553ad4f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_673fcfdfbfa4a345bd12839f8ea31416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a805294da5e5adba679542175d108447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80a37754800a451341b8f068df1ed27b |
| publicationDate |
2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2393514-A1 |
| titleOfInvention |
Dual inhibition of immunophilin/cyclophilin and emmprin immunoglobulin receptor superfamily members |
| abstract |
The present disclosure provides methods and compositions for modulating an adaptive immune response without significantly affecting an innate immunity response in a subject by modulating a combination of an Immunophilin/Cyclophilin Family Member and an EMMPRIN Immunoglobulin Receptor Superfamily Member. The present invention also provides methods and compositions for treating a variety of clinical conditions by modulating an Immunophilin/Cyclophilin Family Member and an EMMPRIN Immunoglobulin Receptor Superfamily Member. |
| priorityDate |
2009-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |